Drug
Abbv 8736
Abbv 8736: highest development phase Phase 1, developed by AbbVie. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- AbbVie
Trials
| Drug | Phase | Indication |
|---|---|---|
| ABBV-8736 NCT07413133 | Phase 1 | Healthy Volunteer |
Latest
No recent events.
Follow Abbv 8736 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.